Evidence map›Paper›PMID 29211319›Full record

ReviewJournal of internal medicine2018

Clinical implications of bone marrow adiposity.

A G Veldhuis-Vlug, C J Rosen

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of internal medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 126 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
126citing papers in PubMed, 3 pooled it
16.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

126 citing papers in PubMed, 3 syntheses or guidelines pooled it, 230 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Aging-Driven Inter-Organ Crosstalk in Postmenopausal Osteoporosis: From Immunometabolic Drift to Multisystem Frailty.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  17. Review
  18. Article
  19. Review
  20. Article

66 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

A G Veldhuis-VlugDepartment of Endocrinology and Metabolism, Academic Medical Center, Amsterdam, The Netherlands.ORCID 0000-0003-0277-2533
C J RosenCenter for Clinical and Translational Research, Maine Medical Center Research Institute, Scarborough, ME, USA.
Amsterdam UMC Location University of Amsterdam · NLMaine Medical Center Research Institute · US

Funding

Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism & Energy BalanceR24DK092759 · NIDDK · MAINEHEALTH · PI HOROWITZ, MARK C, MACDOUGALD, ORMOND A · 2011 to 2019
$13.0M
PTH resistance and marrow adipogenesisR01DK112374 · NIDDK · HARVARD MEDICAL SCHOOL · PI BARON, ROLAND E, ROSEN, CLIFFORD JAMES · 2017 to 2020
$2.2M
Cellular Mechanisms of PTH1R Activation with Osteoporosis TreatmentsR21AR071739 · NIAMS · MAINEHEALTH · PI BLACK, DENNIS M, ROSEN, CLIFFORD JAMES · 2017 to 2018
$581k
Interdisciplinary study of marrow adiposity, mineral metabolism,and energy balancR24DK084970 · NIDDK · MAINEHEALTH · PI HOROWITZ, MARK C, KLIBANSKI, ANNE · 2010 to 2010
$501k
PTH resistance and marrow adipogenesisR56DK112374 · NIDDK · HARVARD MEDICAL SCHOOL · PI MANNSTADT, BEATE, ROSEN, CLIFFORD JAMES · 2016 to 2016
$85k
NIAMS NIH HHS R21 AR071739NIDDK NIH HHS R01 DK112374NIDDK NIH HHS R24 DK084970NIDDK NIH HHS R24 DK092759NIDDK NIH HHS R56 DK112374
6 · The paper itself

Abstract

Marrow adipocytes, collectively termed marrow adipose tissue (MAT), reside in the bone marrow in close contact to bone cells and haematopoietic cells. Marrow adipocytes arise from the mesenchymal stem cell and share their origin with the osteoblast. Shifts in the lineage allocation of the mesenchymal stromal cell could potentially explain the association between increased MAT and increased fracture risk in diseases such as postmenopausal osteoporosis, anorexia nervosa and diabetes. Functionally, marrow adipocytes secrete adipokines, such as adiponectin, and cytokines, such as RANK ligand and stem cell factor. These mediators can influence both bone remodelling and haematopoiesis by promoting bone resorption and haematopoietic recovery following chemotherapy. In addition, marrow adipocytes can secrete free fatty acids, acting as a energy supply for bone and haematopoietic cells. However, this induced lipolysis is also used by neoplastic cells to promote survival and proliferation. Therefore, MAT could represent a new therapeutic target for multiple diseases from osteoporosis to leukaemia, although the exact characteristics and role of the marrow adipocyte in health and diseases remain to be determined.

Indexed as

AdipocytesAdiposityAgingAnimalsAnorexia NervosaBone MarrowGrowthHumansMenopauseNeoplasmsObesityOsteoporosisbone marrow adipocytebone remodellinghaematopoiesismesenchymal stem cell

Identifiers

PMID29211319
PMCPMC5847297
OpenAlexW2773882111

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.